Avalon GloboCare (NASDAQ:AVCO) and GE Healthcare (NYSE:GE) Announce Strategic Partnership to Accelerate Standardized Automation and Bio-Production for Cellular Medicines
Avalon GloboCare Corp. (NASDAQ:AVCO), a leading clinical-stage global developer of cell-based technologies and therapeutics, today announced that they have established a strategic partnership with GE Healthcare (NYSE:GE) . The partnership will accelerate Avalon's standardization, automation and bio-production for clinical-grade Chimeric Antigen Receptor (CAR)-T cells and other immune-effector cells for cellular immunotherapy, as well as exosomes/extracellular vesicles (EV) based regenerative therapeutics. The combination of expertise sets the stage for Avalon to be the leader in cellular medicines with the ability to...
View full press release